Washington, D.C. — The ongoing tug-of-war over autism research in the United States has intensified, particularly following the recent restructuring of a federal advisory panel by Health and Human Services Secretary Robert F. Kennedy Jr. Just days before its inaugural public meeting, originally set for March 19, the Interagency Autism Coordinating Committee (IACC) abruptly canceled the event on March 7, 2026. This decision has prompted consternation among researchers and advocates, leading to the formation of an independent coalition aimed at filling the apparent void left by the government’s actions.
On January 28, the Department of Health and Human Services announced the appointment of 21 new members to the IACC, a body responsible for guiding the allocation of approximately $2 billion each year for autism research and services. However, the overhaul replaced all previous public participants, raising concerns about the committee’s scientific integrity and focus. Among the newly appointed members are individuals known for promoting skepticism about vaccines, including the founder of the Autism Action Network and a researcher linked with the Brownstone Institute for Social and Economic Research.
The exclusion of representatives from established organizations like the Simons Foundation and Autism Speaks, groups that have significantly contributed to autism research over the past two decades, has elicited swift backlash. Responding to the committee’s changes, a coalition of prominent researchers, many of whom were unceremoniously removed from the IACC, launched the Independent Autism Coordinating Committee. This new organization aims to set its own research priorities and will convene its first meeting in direct competition with the canceled government gathering.
David Mandell, a psychiatrist and autism researcher at the University of Pennsylvania, expressed grave concerns regarding the new appointments. He highlighted that many seem to endorse unproven and potentially harmful theories related to autism causation and care strategies. The committee’s shift comes as the Centers for Disease Control and Prevention reaffirms its approach to investigating the discredited link between vaccines and autism, a move that has sparked further criticism in the scientific community.
In November 2025, the CDC altered its autism information page, stating that the assertion that vaccines do not trigger autism lacked evidentiary backing. This modification raised eyebrows among medical professionals, who voiced their objections to the agency’s lack of consultation with them prior to its announcement.
Alison Singer, head of the Autism Science Foundation and a former committee member, slammed the new configuration as a “complete overhaul” devoid of continuity and scientific expertise. Joshua Gordon, the former director of the National Institute of Mental Health, also noted that none of the committee’s new appointees are recognized autism experts.
The restructured committee has also seen a decline in representation of self-advocates, from seven to just three, breaching statutory minimums. Critics such as Sam Crane, a disability law specialist and former committee member, have decried the opaque selection process and affirmed that the voices of those with autism are being sidelined.
Dr. Sylvia Fogel, an incoming chair of the reformed committee, has acknowledged the lack of substantial evidence supporting a vaccine-autism connection. This has raised significant alarms among communities invested in autism advocacy.
Political divisions surrounding this issue have surfaced even among Congressional Republicans. Bill Cassidy, chair of the Senate Health, Education, Labor, and Pensions Committee, cautioned against revisiting debunked theories about vaccines, adding that such approaches can lead to anxiety among families. Meanwhile, Susan Collins, who has a personal connection to autism, called for a clearer focus on scientific consensus rather than speculative links to vaccines.
A recent evaluation of Kennedy’s actions revealed that he had deviated significantly from promises made during his confirmation process, including reductions in vaccine research funding. This past month, a federal magistrate in Boston ruled against Kennedy’s broader vaccine policy changes, criticizing the government’s disregard for established scientific procedures.
As the federal committee grapples with its futures, the independent group remains steadfast in its commitment to advancing research based on credible evidence. With mounting tensions and challenges ahead, advocates fear that the landscape of federal autism research may shift away from established science toward unproven claims, posing potential risks to ongoing efforts aimed at understanding and supporting individuals with autism.